EAB Member John Maroney Named President, CEO and Director of VISION5

External Advisory Board member John F. Maroney will join ForSight VISION5 as President, CEO and Director of VISION5, and that the company has recently closed its Series B-1 round of funding. ForSight VISION5 is the fifth company created by Menlo Park ophthalmic incubator ForSight Labs. VISION5 is a clinical development stage company focused on unmet needs in ophthalmic diseases, initially ocular hypertension and glaucoma. Full story here.